Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis

Nephron - Experimental Nephrology

Volumn 117, Issue 1, 2010, Pages

  Ito, Yasuhiko ^a,b   Aten, Jan ^a   Nguyen, Tri Q ^c   Joles, Jaap A ^c   Matsuo, Seiichi ^b   Weening, Jan J ^a   Goldschmeding, Roel ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Fibrosis; Focal segmental glomerulosclerosis; Hypertension; Nephrosclerosis; Proteinuria; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; HYPERTENSION; HYPERTENSIVE NEPHROSCLEROSIS; KIDNEY FIBROSIS; MALE; NEPHROSCLEROSIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; TUBULOINTERSTITIAL FIBROSIS;

ADULT; AGED; ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MIDDLE AGED; NEPHRECTOMY; NEPHROSCLEROSIS; RATS; RATS, INBRED SHR; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77955097526     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319652     Document Type: Article

References (31)

1. Barri YM: Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep 2008; 10: 39-45.
2. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992; 175: 1413-1416.
3. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-1358.
4. Gupta S, Clarkson MR, Duggan J, Brady HR: Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 2000; 58: 1389-1399.
5. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR: Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999; 274: 5830-5834.
6. Igarashi A, Okochi H, Bradham DM, Grotendorst GR: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993; 4: 637-645.
7. Kanemoto K, Usui J, Tomari S, Yokoi H, Mukoyama M, Aten J, Weening JJ, Nagata M: Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. Lab Invest 2003; 83: 1615-1625.
8. Weston BS, Wahab NA, Mason RM: CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha- 5beta1 integrin in human mesangial cells. J Am Soc Nephrol 2003; 14: 601-610.
9. Nguyen TQ, Goldschmeding R: Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm Res 2008; 25: 2416-2426.
10. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998; 53: 853-861.
11. de las Heras N, Ruiz-Ortega M, Ruperez M, Sanz-Rosa D, Miana M, Aragoncillo P, Mezzano S, Lahera V, Egido J, Cachofeiro V: Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II. J Renin Angiotensin Aldosterone Syst 2006; 7: 192-200.
12. de las Heras N, Ruiz-Ortega M, Miana M, Ruperez M, Sanz-Rosa D, Aragoncillo P, Mezzano S, Cachofeiro V, Egido J, Lahera V: Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats. J Hypertens 2007; 25: 629-638.
13. Dworkin LD, Feiner HD: Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension. J Clin Invest 1986; 77: 797-809.
14. Geiger H, Fierlbeck W, Mai M, Ruchti H, Schonfeld V, Dammrich J, Hugo C, Neumayer HH: Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR. Kidney Int 1997; 51: 750-761.
15. Vassalotti JA, Stevens LA, Levey AS: Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 2007; 50: 169-180.
16. Roestenberg P, van Nieuwenhoven FA, Wieten L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W, Weitz S, Schlingemann RO, Goldschmeding R: Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care 2004; 27: 1164-1170.
17. Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, Goldschmeding R, van Nieuwenhoven FA: Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006; 29: 83-88.
18. Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, Oliver N, Aten J, Hoppener JW, Goldschmeding R: Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol 2006; 290:F1344-F1354.
19. Nguyen TQ, Roestenberg P, van Nieuwenhoven FA, Bovenschen N, Li Z, Xu L, Oliver N, Aten J, Joles JA, Vial C, Brandan E, Lyons KM, Goldschmeding R: CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 2098-2107.
20. Ito Y, Goldschmeding R, Bende R, Claessen N, Chand M, Kleij L, Rabelink T, Weening J, Aten J: Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 2001; 12: 472-484.
21. Turk T, Leeuwis JW, Gray J, Torti SV, Lyons KM, Nguyen TQ, Goldschmeding R: BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression. J Histochem Cytochem 2009; 57: 623-631.
22. Ott C, Iwanciw D, Graness A, Giehl K, Goppelt- Struebe M: Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton. J Biol Chem 2003; 278: 44305-44311. (Pubitemid 37377176)
23. Oba S, Kimura K, Suzuki N, Mise N, Tojo A, Miyashita K, Konno Y, Hirata Y, Goto A, Omata M: Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis. Am J Kidney Dis 1998; 32: 419-425.
24. Risdon RA, Sloper JC, De Wardener HE: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968;ii:363-366.
25. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508.
26. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350.
27. Liu BC, Zhang JD, Zhang XL, Wu GQ, Li MX: Role of connective tissue growth factor (CTGF) module 4 in regulating epithelial mesenchymal transition (EMT) in HK-2 cells. Clin Chim Acta 2006; 373: 144-150.
28. Shi Y, Tu Z, Wang W, Li Q, Ye F, Wang J, Qiu J, Zhang L, Bu H, Li Y: Homologous peptide of connective tissue growth factor ameliorates epithelial to mesenchymal transition of tubular epithelial cells. Cytokine 2006; 36: 35-44. (Pubitemid 46049019)
29. Owens GK: Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987; 9: 178-187.
30. Owens GK, Schwartz SM: Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res 1982; 51: 280-289.
31. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ: Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993; 22: 523-526. (Pubitemid 23292158)